Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study

Allergy
K KrauseM Maurer

Abstract

Schnitzler syndrome (SchS) is a rare disease with suspected autoinflammatory background that shares several clinical symptoms, including urticarial rash, fever episodes, arthralgia, and bone and muscle pain with cryopyrin-associated periodic syndromes (CAPS). Cryopyrin-associated periodic syndromes respond to treatment with interleukin-1 antagonists, and single case reports of Schnitzler syndrome have shown improvement following treatment with the interleukin-1 blocker anakinra. This study evaluated the effects of the interleukin-1 antagonist rilonacept on the clinical signs and symptoms of SchS. Eight patients with SchS were included in this prospective, single-center, open-label study. After a 3-week baseline, patients received a subcutaneous loading dose of rilonacept 320 mg followed by weekly subcutaneous doses of 160 mg for up to 1 year. Efficacy was determined by patient-based daily health assessment forms, physician's global assessment (PGA), and measurement of inflammatory markers including C-reactive protein (CRP), serum amyloid A (SAA), and S100 calcium-binding protein A12 (S100A12). Treatment with rilonacept resulted in a rapid clinical response as demonstrated by significant reductions in daily health assessment sco...Continue Reading

References

Dec 17, 2002·Nature Medicine·Aris N EconomidesNeil Stahl
Dec 14, 2004·Arthritis and Rheumatism·Dirk Foell, Johannes Roth
Jun 30, 2005·Arthritis and Rheumatism·Victor Manuel Martinez-TaboadaJose Luis Fernández-Luna
Aug 23, 2006·Cell·Yasunori OguraRichard A Flavell
Apr 17, 2007·Journal of the American Academy of Dermatology·Stefan W SchneiderGisela Bonsmann
Jun 26, 2007·Seminars in Arthritis and Rheumatism·Heleen D de KoningUNKNOWN Schnitzler Syndrome Study Group
Oct 16, 2007·The Journal of Allergy and Clinical Immunology·John G RyanAnna Simon
Nov 6, 2007·Current Opinion in Immunology·Virginie PétrilliJürg Tschopp
Apr 15, 2009·The Journal of Experimental Medicine·Helen J LachmannThomas Jung
Jun 6, 2009·The New England Journal of Medicine·Helen J LachmannUNKNOWN Canakinumab in CAPS Study Group
Aug 22, 2009·Rheumatology·Cinzia PizziraniAndrea Lo Monaco
Feb 18, 2010·The Journal of Allergy and Clinical Immunology·Jan LoockWolfgang L Gross
May 25, 2010·European Journal of Internal Medicine·Ioannis MitroulisKonstantinos Ritis
Oct 13, 2010·Scandinavian Journal of Rheumatology·J T GranP Aukrust
Dec 15, 2010·Orphanet Journal of Rare Diseases·Dan Lipsker
Mar 2, 2011·Arthritis and Rheumatism·Jasmin B Kuemmerle-DeschnerSusanne M Benseler
Jun 28, 2011·The Journal of Allergy and Clinical Immunology·Heleen D de KoningAnna Simon
Dec 14, 2011·The Journal of Allergy and Clinical Immunology·Karoline KrauseMarcus Maurer

❮ Previous
Next ❯

Citations

Sep 28, 2013·La Revue de médecine interne·M HelloM Hamidou
May 15, 2013·Nature Reviews. Rheumatology·Alexander SoNathalie Busso
Nov 28, 2013·Seminars in Immunology·Charles A Dinarello, Jos W M van der Meer
May 24, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Monika Moll, Jasmin B Kuemmerle-Deschner
Apr 8, 2014·Joint, Bone, Spine : Revue Du Rhumatisme·Alexander So, Nathalie Busso
Feb 13, 2016·The Journal of Dermatological Treatment·Astrid SönnichsenEmmanuella Guenova
Nov 23, 2013·Immunology and Allergy Clinics of North America·Torsten ZuberbierMarcus Maurer
Aug 21, 2012·Seminars in Arthritis and Rheumatism·Steven Vanderschueren, Daniël Knockaert
Dec 15, 2015·Nature Reviews. Rheumatology·Georg SchettBernhard Manger
Mar 7, 2014·The Journal of Investigative Dermatology·Hans-Dietmar BeerLars E French
Mar 14, 2013·Allergy·A SimonD Lipsker
Jul 30, 2014·The British Journal of Dermatology·R A Sabroe
Oct 7, 2014·Allergy·C Schlapbach, D Simon
Sep 1, 2015·Clinics in Dermatology·Bediha Bölükbasi, Karoline Krause
Jun 11, 2015·Seminars in Immunopathology·Tilmann Kallinich
Jul 23, 2015·Arthritis Research & Therapy·Heleen D de KoningAnna Simon
Feb 3, 2015·The Journal of Clinical Investigation·Tyler K UllandFayyaz S Sutterwala
May 31, 2016·Clinical and Experimental Dermatology·A GameiroM Gonçalo
Oct 6, 2016·Revista clínica española·A González GarcíaN Ortego Centeno
Oct 30, 2016·The Journal of Allergy and Clinical Immunology·Karoline KrauseMarcus Maurer
Jun 7, 2017·Expert Review of Clinical Pharmacology·Emmanuelle C Landmann, Ulrich A Walker
Nov 17, 2015·Therapeutic Advances in Chronic Disease·Christian Vestergaard, Mette Deleuran
Oct 20, 2018·The British Journal of Dermatology·K KrauseK Wolk
Jan 18, 2019·Expert Review of Clinical Immunology·Judith Sánchez-ManubensJordi Anton
Jun 6, 2019·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·F F Gellrich, C Günther
Aug 17, 2019·Italian Journal of Pediatrics·Carlo CaffarelliFabio Cardinale
Apr 8, 2020·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·J Ehrchen, C Drerup
Sep 1, 2018·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·F F Gellrich, C Günther
Nov 27, 2019·Rheumatology·Mark KacarSinisa Savic
Jan 1, 2014·Clinical and Translational Allergy·Heleen D de Koning
May 1, 2018·Case Reports in Rheumatology·Maaman BashirRichard Hariman
Jul 19, 2017·Current Rheumatology Reports·L Gusdorf, D Lipsker
Jan 23, 2019·Zeitschrift für Rheumatologie·F F Gellrich, C Günther
Aug 10, 2020·Immunological Reviews·Dhruv ChauhanMohamed Lamkanfi
Jun 8, 2017·Frontiers in Pharmacology·Gabriele FeniniLars E French
Feb 13, 2018·Immunological Reviews·Hanna BonnekohKaroline Krause
Apr 19, 2019·American Journal of Clinical Dermatology·Annika Havnaer, George Han
Dec 10, 2020·Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia·Laurence Gusdorf, Dan Lipsker
Feb 6, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Hanna BonnekohKaroline Krause

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.